Unexpected better outcome in a liver transplant recipient with COVID-19: a beneficial effect of tacrolimus?

摘要

Coronavirus disease 2019 (COVID-19) is a serious respiratory illness caused by the SARS-CoV-2 virus. 1 At present, data on COVID-19 in liver transplant (LT) recipients are scarce, and there is controversy about whether their immunosup- pressive status is a risk factor or a protective factor for developing severe disease. International teams have pub- lished that immunosuppression does not represent a higher risk for developing severe pneumonia .